|
|
| Kaynak: Yahoo Finance 10-30-2021 06:00:05 |  Landmark Bio™, a collective endeavor launched by leaders from academia, the life sciences industry, and world-renowned research hospitals to accelerate development and industrialization of novel therapeutics, today announced the appointment of two new leaders to its executive team: Gregg Nyberg, Ph.D., as chief technology officer (CTO) and Michael Covington as chief quality and regulatory officer (CQRO).
Tümünü Oku |
| | | | | | | | |
|
